ArticleClinical rheumatology2025

Development and validation of a prediction model for serious infections in rheumatoid arthritis patients treated with tocilizumab in Japan.

Toshihiro Nanki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.